Global Novel Drug Delivery Systems (NDDS) Market - Segmented by Route of Administration, Mode of NDDS, Geography - Growth, Trends, and Forecast (2022 - 2030)
The novel drug delivery systems market is expected to witness a CAGR of 2.9%, during the forecast period, 2018-2023. There is a continuous growth in the market of drug delivery systems and is forecasted to continue to grow at an impressive rate in future also.
Requirement of Controlled Release of Drugs
The method by which a drug is being delivered can have significant influence on its efficacy. Many of the drugs have an optimum concentration range and requirement of controlled release of drugs in the body has to be there. The concentrations above or below the concentration range can be toxic or can produce no therapeutic benefits at all. Transdermal patches, implants, nasal systems, microcapsules, etc. are some of the common systems that are considered under the controlled release systems. Hence, the requirement of controlled release of drugs leads to drive the novel drug delivery systems market.
The other factors include advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS) and technological advancements promoting development of NDDS.
Stability Issues with the NDDS System
The stability of the delivery system is one of the most important factors, which effects the drug delivery systems market. Liposomes are the most common nanocarriers for drug delivery owing to the several advantages they offer over other delivery systems. Liposomes help in stabilizing therapeutic compounds and improved biodistribution of compounds to target sites in vivo. However, stability of liposome-based drug delivery systems is a major concern, which is restraining the growth of this market.
The other restraining factors also include the stringent regulatory guidelines and product recalls.
North America Dominates the Market
North America has dominated the novel drug delivery systems in cancer therapy market in 2016 with a revenue share of around 37%. North America holds the major share in the market owing to the factors, such as growing R&D in the field of drug delivery systems, the high adoption rate of new technologies, and supportive reimbursement policies. Asia Pacific is also expected to witness growth in the novel drug delivery systems market in the upcoming future.
Key Developments in the Market
• November 2017: Juluca (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection
Major players- ABBOTT LABORATORIES, ASTRAZENECA PLC, BAYER HEALTHCARE PHARMACEUTICALS, GLAXOSMITHKLINE PLC, JOHNSON & JOHNSON, MERCK & CO., NOVARTIS AG, PFIZER INC., ROCHE HOLDING AG AND SANOFI SA, among others.
Reasons to Purchase this Report
• Current and future novel drug delivery systems market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs
Requirement of Controlled Release of Drugs
The method by which a drug is being delivered can have significant influence on its efficacy. Many of the drugs have an optimum concentration range and requirement of controlled release of drugs in the body has to be there. The concentrations above or below the concentration range can be toxic or can produce no therapeutic benefits at all. Transdermal patches, implants, nasal systems, microcapsules, etc. are some of the common systems that are considered under the controlled release systems. Hence, the requirement of controlled release of drugs leads to drive the novel drug delivery systems market.
The other factors include advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS) and technological advancements promoting development of NDDS.
Stability Issues with the NDDS System
The stability of the delivery system is one of the most important factors, which effects the drug delivery systems market. Liposomes are the most common nanocarriers for drug delivery owing to the several advantages they offer over other delivery systems. Liposomes help in stabilizing therapeutic compounds and improved biodistribution of compounds to target sites in vivo. However, stability of liposome-based drug delivery systems is a major concern, which is restraining the growth of this market.
The other restraining factors also include the stringent regulatory guidelines and product recalls.
North America Dominates the Market
North America has dominated the novel drug delivery systems in cancer therapy market in 2016 with a revenue share of around 37%. North America holds the major share in the market owing to the factors, such as growing R&D in the field of drug delivery systems, the high adoption rate of new technologies, and supportive reimbursement policies. Asia Pacific is also expected to witness growth in the novel drug delivery systems market in the upcoming future.
Key Developments in the Market
• November 2017: Juluca (dolutegravir and rilpivirine) approved in US as first 2-drug regimen, once-daily, single pill a complete regimen for the maintenance treatment of virologically suppressed HIV-1 infection
Major players- ABBOTT LABORATORIES, ASTRAZENECA PLC, BAYER HEALTHCARE PHARMACEUTICALS, GLAXOSMITHKLINE PLC, JOHNSON & JOHNSON, MERCK & CO., NOVARTIS AG, PFIZER INC., ROCHE HOLDING AG AND SANOFI SA, among others.
Reasons to Purchase this Report
• Current and future novel drug delivery systems market outlook in the developed and emerging markets
• Analyzing various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
